APO RESEARCH · REPORT
Veterinary Drug
Veterinary drugs are used to cure and prevent diseases in animals, including animals used for food production. Veterinary drugs are given to animals via feed or drinking water, or by injection.
Product & engineering
Understand the product.
Veterinary drugs are used to cure and prevent diseases in animals, including animals used for food production. Veterinary drugs are given to animals via feed or drinking water, or by injection.
Selected research
Industry Research
Veterinary Drug Industry Research Report 2026
Market perspective
Veterinary drugs are used to cure and prevent diseases in animals, including animals used for food production. Veterinary drugs are given to animals via feed or drinking water, or by injection.
The key players of Veterinary Drug include Zoetis, Elanco, Boehringer Ingelheim, Merck, etc. The top four players of Veterinary Drug account for approximately 56% of the total market. Asia-Pacific is the largest market of Veterinary Drug accounting for about 34%, followed by Europe and North America. In terms of Type, Parasiticides is the largest segment, with a share about 28%. And in terms of Application, the largest application is Pets, followed by Cattle.
Report Scope
Read the full market overview
This report quantifies the global Veterinary Drug market in terms of revenue (US$ million) and, where applicable, sales volume (M Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Veterinary Drug Market by Company
Zoetis
Elanco
Boehringer Ingelheim
Merck
Virbac
Ceva
Vetoquinol
Dechra
Norbrook
Phibro
Huvepharma
Hipra
Ouro Fino Saude
CAHIC
Orion
Ringpu Biology
Nippon Zenyaku Kogyo
Farmavet-Pasteur
Veterinary Drug Segment by Type
Anti-Infectives
Anti-Inflammatory
Parasiticides
Analgesics
Sedatives
Others
Veterinary Drug Segment by Application
Pets
Cattle
Poultry
Swine
Others
Veterinary Drug Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Veterinary Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Drug.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Veterinary Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Veterinary Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Veterinary Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Anti-Infectives
- Anti-Inflammatory
- Parasiticides
- Analgesics
- Sedatives
- Others
Applications
- Pets
- Cattle
- Poultry
- Swine
- Others
Companies covered
- Zoetis
- Elanco
- Boehringer Ingelheim
- Merck
- Virbac
- Ceva
- Vetoquinol
- Dechra
- Norbrook
- Phibro
- Huvepharma
- Hipra
- Ouro Fino Saude
- CAHIC
- Orion
- Ringpu Biology
- Nippon Zenyaku Kogyo
- Farmavet-Pasteur
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Veterinary Drug Market Size (2021-2032)
- 2.2.2 Global Veterinary Drug Sales (2021-2032)
- 2.2.3 Global Veterinary Drug Market Average Price (2021-2032)
- 2.3 Veterinary Drug by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Anti-Infectives
- 2.3.3 Anti-Inflammatory
- 2.3.4 Parasiticides
- 2.3.5 Analgesics
- 2.3.6 Sedatives
- 2.3.7 Others
- 2.4 Veterinary Drug by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Pets
- 2.4.3 Cattle
- 2.4.4 Poultry
- 2.4.5 Swine
- 2.4.6 Others
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Veterinary Drug Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Veterinary Drug Sales (M Units) of Manufacturers (2021-2026)
- 3.3 Global Veterinary Drug Revenue of Manufacturers (2021-2026)
- 3.4 Global Veterinary Drug Average Price by Manufacturers (2021-2026)
- 3.5 Global Veterinary Drug Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Veterinary Drug, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Veterinary Drug, Product Type & Application
- 3.8 Global Manufacturers of Veterinary Drug, Established Date
- 3.9 Global Veterinary Drug Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Zoetis
- 4.1.1 Zoetis Company Information
- 4.1.2 Zoetis Business Overview
- 4.1.3 Zoetis Veterinary Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 Zoetis Veterinary Drug Product Portfolio
- 4.1.5 Zoetis Recent Developments
- 4.2 Elanco
- 4.2.1 Elanco Company Information
- 4.2.2 Elanco Business Overview
- 4.2.3 Elanco Veterinary Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Elanco Veterinary Drug Product Portfolio
- 4.2.5 Elanco Recent Developments
- 4.3 Boehringer Ingelheim
- 4.3.1 Boehringer Ingelheim Company Information
- 4.3.2 Boehringer Ingelheim Business Overview
- 4.3.3 Boehringer Ingelheim Veterinary Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Boehringer Ingelheim Veterinary Drug Product Portfolio
- 4.3.5 Boehringer Ingelheim Recent Developments
- 4.4 Merck
- 4.4.1 Merck Company Information
- 4.4.2 Merck Business Overview
- 4.4.3 Merck Veterinary Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Merck Veterinary Drug Product Portfolio
- 4.4.5 Merck Recent Developments
- 4.5 Virbac
- 4.5.1 Virbac Company Information
- 4.5.2 Virbac Business Overview
- 4.5.3 Virbac Veterinary Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Virbac Veterinary Drug Product Portfolio
- 4.5.5 Virbac Recent Developments
- 4.6 Ceva
- 4.6.1 Ceva Company Information
- 4.6.2 Ceva Business Overview
- 4.6.3 Ceva Veterinary Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Ceva Veterinary Drug Product Portfolio
- 4.6.5 Ceva Recent Developments
- 4.7 Vetoquinol
- 4.7.1 Vetoquinol Company Information
- 4.7.2 Vetoquinol Business Overview
- 4.7.3 Vetoquinol Veterinary Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 Vetoquinol Veterinary Drug Product Portfolio
- 4.7.5 Vetoquinol Recent Developments
- 4.8 Dechra
- 4.8.1 Dechra Company Information
- 4.8.2 Dechra Business Overview
- 4.8.3 Dechra Veterinary Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 Dechra Veterinary Drug Product Portfolio
- 4.8.5 Dechra Recent Developments
- 4.9 Norbrook
- 4.9.1 Norbrook Company Information
- 4.9.2 Norbrook Business Overview
- 4.9.3 Norbrook Veterinary Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Norbrook Veterinary Drug Product Portfolio
- 4.9.5 Norbrook Recent Developments
- 4.10 Phibro
- 4.10.1 Phibro Company Information
- 4.10.2 Phibro Business Overview
- 4.10.3 Phibro Veterinary Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 Phibro Veterinary Drug Product Portfolio
- 4.10.5 Phibro Recent Developments
- 4.11 Huvepharma
- 4.11.1 Huvepharma Company Information
- 4.11.2 Huvepharma Business Overview
- 4.11.3 Huvepharma Veterinary Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 Huvepharma Veterinary Drug Product Portfolio
- 4.11.5 Huvepharma Recent Developments
- 4.12 Hipra
- 4.12.1 Hipra Company Information
- 4.12.2 Hipra Business Overview
- 4.12.3 Hipra Veterinary Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Hipra Veterinary Drug Product Portfolio
- 4.12.5 Hipra Recent Developments
- 4.13 Ouro Fino Saude
- 4.13.1 Ouro Fino Saude Company Information
- 4.13.2 Ouro Fino Saude Business Overview
- 4.13.3 Ouro Fino Saude Veterinary Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Ouro Fino Saude Veterinary Drug Product Portfolio
- 4.13.5 Ouro Fino Saude Recent Developments
- 4.14 CAHIC
- 4.14.1 CAHIC Company Information
- 4.14.2 CAHIC Business Overview
- 4.14.3 CAHIC Veterinary Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 CAHIC Veterinary Drug Product Portfolio
- 4.14.5 CAHIC Recent Developments
- 4.15 Orion
- 4.15.1 Orion Company Information
- 4.15.2 Orion Business Overview
- 4.15.3 Orion Veterinary Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Orion Veterinary Drug Product Portfolio
- 4.15.5 Orion Recent Developments
- 4.16 Ringpu Biology
- 4.16.1 Ringpu Biology Company Information
- 4.16.2 Ringpu Biology Business Overview
- 4.16.3 Ringpu Biology Veterinary Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Ringpu Biology Veterinary Drug Product Portfolio
- 4.16.5 Ringpu Biology Recent Developments
- 4.17 Nippon Zenyaku Kogyo
- 4.17.1 Nippon Zenyaku Kogyo Company Information
- 4.17.2 Nippon Zenyaku Kogyo Business Overview
- 4.17.3 Nippon Zenyaku Kogyo Veterinary Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.17.4 Nippon Zenyaku Kogyo Veterinary Drug Product Portfolio
- 4.17.5 Nippon Zenyaku Kogyo Recent Developments
- 4.18 Farmavet-Pasteur
- 4.18.1 Farmavet-Pasteur Company Information
- 4.18.2 Farmavet-Pasteur Business Overview
- 4.18.3 Farmavet-Pasteur Veterinary Drug Sales, Revenue and Gross Margin (2021-2026)
- 4.18.4 Farmavet-Pasteur Veterinary Drug Product Portfolio
- 4.18.5 Farmavet-Pasteur Recent Developments
5 Global Veterinary Drug Market Scenario by Region
- 5.1 Global Veterinary Drug Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Veterinary Drug Sales by Region: 2021-2032
- 5.2.1 Global Veterinary Drug Sales by Region: 2021-2026
- 5.2.2 Global Veterinary Drug Sales by Region: 2027-2032
- 5.3 Global Veterinary Drug Revenue by Region: 2021-2032
- 5.3.1 Global Veterinary Drug Revenue by Region: 2021-2026
- 5.3.2 Global Veterinary Drug Revenue by Region: 2027-2032
- 5.4 North America Veterinary Drug Market Facts & Figures by Country
- 5.4.1 North America Veterinary Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Veterinary Drug Sales by Country (2021-2032)
- 5.4.3 North America Veterinary Drug Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Veterinary Drug Market Facts & Figures by Country
- 5.5.1 Europe Veterinary Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Veterinary Drug Sales by Country (2021-2032)
- 5.5.3 Europe Veterinary Drug Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Veterinary Drug Market Facts & Figures by Country
- 5.6.1 Asia Pacific Veterinary Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Veterinary Drug Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Veterinary Drug Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Veterinary Drug Market Facts & Figures by Country
- 5.7.1 South America Veterinary Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Veterinary Drug Sales by Country (2021-2032)
- 5.7.3 South America Veterinary Drug Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Veterinary Drug Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Veterinary Drug Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Veterinary Drug Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Veterinary Drug Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Veterinary Drug Sales by Type (2021-2032)
- 6.1.1 Global Veterinary Drug Sales by Type (2021-2032) & (M Units)
- 6.1.2 Global Veterinary Drug Sales Market Share by Type (2021-2032)
- 6.2 Global Veterinary Drug Revenue by Type (2021-2032)
- 6.2.1 Global Veterinary Drug Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Veterinary Drug Revenue Market Share by Type (2021-2032)
- 6.3 Global Veterinary Drug Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Veterinary Drug Sales by Application (2021-2032)
- 7.1.1 Global Veterinary Drug Sales by Application (2021-2032) & (M Units)
- 7.1.2 Global Veterinary Drug Sales Market Share by Application (2021-2032)
- 7.2 Global Veterinary Drug Revenue by Application (2021-2032)
- 7.2.1 Global Veterinary Drug Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Veterinary Drug Revenue Market Share by Application (2021-2032)
- 7.3 Global Veterinary Drug Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Veterinary Drug Value Chain Analysis
- 8.1.1 Veterinary Drug Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Veterinary Drug Production Mode & Process
- 8.2 Veterinary Drug Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Veterinary Drug Distributors
- 8.2.3 Veterinary Drug Customers
9 Global Veterinary Drug Analyzing Market Dynamics
- 9.1 Veterinary Drug Industry Trends
- 9.2 Veterinary Drug Industry Drivers
- 9.3 Veterinary Drug Industry Opportunities and Challenges
- 9.4 Veterinary Drug Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst